REGN

Regeneron Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$761.85

Market Cap

$79.16B

Beta

0.40

P/E

18.3

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.99%

EPS Growth (YoY)+8.57%

Revenue CAGR 3Y+5.62%

P/E Ratio18.3

PEG Ratio2.14

FCF Yield+5.15%

Debt / Equity0.09

Interest Coverage81.7x

No credit card required

Already have an account? Sign in to view the full analysis for REGN.